Athira Pharma Statistics Share Statistics Athira Pharma has 39.04M
shares outstanding. The number of shares has increased by 1.86%
in one year.
Shares Outstanding 39.04M Shares Change (YoY) 1.86% Shares Change (QoQ) 0.97% Owned by Institutions (%) 46.58% Shares Floating 33.69M Failed to Deliver (FTD) Shares 1,511 FTD / Avg. Volume 0.27%
Short Selling Information The latest short interest is 749.78K, so 1.92% of the outstanding
shares have been sold short.
Short Interest 749.78K Short % of Shares Out 1.92% Short % of Float 2.29% Short Ratio (days to cover) 3.32
Valuation Ratios The PE ratio is -0.23 and the forward
PE ratio is -0.79.
Athira Pharma's PEG ratio is
0.01.
PE Ratio -0.23 Forward PE -0.79 PS Ratio 0 Forward PS n/a PB Ratio 0.5 P/FCF Ratio -0.23 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Athira Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.18,
with a Debt / Equity ratio of 0.03.
Current Ratio 4.18 Quick Ratio 4.18 Debt / Equity 0.03 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.73M Employee Count 26 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -85.88% in the
last 52 weeks. The beta is 3.03, so Athira Pharma's
price volatility has been higher than the market average.
Beta 3.03 52-Week Price Change -85.88% 50-Day Moving Average 0.28 200-Day Moving Average 0.58 Relative Strength Index (RSI) 68.5 Average Volume (20 Days) 567,411
Income Statement
Revenue n/a Gross Profit n/a Operating Income -96.78M Net Income -96.94M EBITDA -95.97M EBIT -96.94M Earnings Per Share (EPS) -2.52
Full Income Statement Balance Sheet The company has 48.44M in cash and 1.22M in
debt, giving a net cash position of 47.22M.
Cash & Cash Equivalents 48.44M Total Debt 1.22M Net Cash 47.22M Retained Earnings -406.15M Total Assets 43.51M Working Capital 34.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -97.17M
and capital expenditures -33K, giving a free cash flow of -97.2M.
Operating Cash Flow -97.17M Capital Expenditures -33K Free Cash Flow -97.2M FCF Per Share -2.53
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
